Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating

Stock Track

02-25

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.

Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.

Additionally, Scotiabank maintained its "Sector Outperform" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1182320766"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1182320766\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1182320766?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-25 01:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182320766","market":"hk","top_or_hot":-1,"title":"Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating","media":"Stock Track","content":"<html><body><p>Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.</p>\n<p>Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.</p>\n<p>Additionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Exact Sciences Soars 5.05% on Monday Amid Investor Conference Participation and Analyst Rating\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-25 01:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.</p>\n<p>Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.</p>\n<p>Additionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EXAS","symbol_name":"精密科學","start_time":0,"source_url":"","article_id":"1182320766","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182320766","pubTimestamp":1740418961,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.Exact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. Du","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EXAS":"精密科学"},"translate_title":"由于投资者会议参与和分析师评级，股票跟踪Exact Sciences周一飙升5.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EXAS":1},"content_text":"Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, saw its stock soar 5.05% on Monday during the trading session. This upward movement came as the company announced its participation in two upcoming investor conferences and received a positive analyst rating.\nExact Sciences revealed that its management team will present at the TD Cowen Health Care Conference in Boston on March 3rd and the Raymond James Institutional Investors Conference in Orlando on March 4th. During these events, the company is expected to provide updates on its business operations and future plans, potentially boosting investor confidence and driving the stock's upward momentum.\nAdditionally, Scotiabank maintained its \"Sector Outperform\" rating on Exact Sciences, indicating the analyst's positive outlook on the company's performance within its sector. This favorable rating likely contributed to the stock's surge, as investors reacted positively to the analyst's endorsement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}